Toward optimal health: advances in breast cancer detection and management. Interview by Jodi R. Godfrey.
Chlebowski
Rowan T
RT
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000517:prevention & control; D005260:Female; D006801:Humans; D008327:Mammography / Q000379:methods; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use; D014481:United States
D018931:Antineoplastic Agents, Hormonal; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride